NO144928C - Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater.

Info

Publication number
NO144928C
NO144928C NO754317A NO754317A NO144928C NO 144928 C NO144928 C NO 144928C NO 754317 A NO754317 A NO 754317A NO 754317 A NO754317 A NO 754317A NO 144928 C NO144928 C NO 144928C
Authority
NO
Norway
Prior art keywords
zantine
derivatives
preparation
physiologically active
analogue procedure
Prior art date
Application number
NO754317A
Other languages
English (en)
Norwegian (no)
Other versions
NO144928B (no
NO754317L (fr
Inventor
Wilhelm Konz
Richard Reichl
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO754317L publication Critical patent/NO754317L/no
Publication of NO144928B publication Critical patent/NO144928B/no
Publication of NO144928C publication Critical patent/NO144928C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO754317A 1974-12-21 1975-12-19 Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater. NO144928C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (3)

Publication Number Publication Date
NO754317L NO754317L (fr) 1976-06-22
NO144928B NO144928B (no) 1981-08-31
NO144928C true NO144928C (no) 1981-12-09

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
NO754317A NO144928C (no) 1974-12-21 1975-12-19 Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater.

Country Status (31)

Country Link
US (1) US3998953A (fr)
JP (1) JPS5188995A (fr)
AT (1) AT341540B (fr)
AU (1) AU501889B2 (fr)
BE (1) BE836898A (fr)
BG (1) BG25518A3 (fr)
CA (1) CA1036159A (fr)
CH (1) CH628346A5 (fr)
CS (1) CS191289B2 (fr)
DD (1) DD124984A5 (fr)
DE (1) DE2460929A1 (fr)
DK (1) DK137677C (fr)
ES (2) ES443738A1 (fr)
FI (1) FI62089C (fr)
FR (1) FR2294706A1 (fr)
GB (1) GB1517710A (fr)
GR (1) GR59204B (fr)
HU (1) HU174673B (fr)
IE (1) IE43208B1 (fr)
IL (1) IL48697A (fr)
LU (1) LU73972A1 (fr)
NL (1) NL7514837A (fr)
NO (1) NO144928C (fr)
NZ (1) NZ179599A (fr)
PH (1) PH11810A (fr)
PL (1) PL99165B1 (fr)
RO (1) RO68381A (fr)
SE (1) SE420493B (fr)
SU (1) SU603340A3 (fr)
YU (1) YU39004B (fr)
ZA (1) ZA757865B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (fr) * 1997-12-17 1999-06-24 University Of South Florida Antagonistes du recepteur de l'adenosine presentant une bioactivite amelioree
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (fr) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (fr) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
NO144928B (no) 1981-08-31
FI62089B (fi) 1982-07-30
FI62089C (fi) 1982-11-10
JPS5188995A (fr) 1976-08-04
IE43208B1 (en) 1981-01-14
ATA904575A (de) 1977-06-15
IL48697A0 (en) 1976-02-29
NO754317L (fr) 1976-06-22
RO68381A (fr) 1982-02-26
YU39004B (en) 1983-12-31
NZ179599A (en) 1978-03-06
YU323475A (en) 1982-08-31
DK137677C (da) 1978-09-25
ZA757865B (en) 1977-08-31
FI753543A (fr) 1976-06-22
FR2294706B1 (fr) 1978-12-01
FR2294706A1 (fr) 1976-07-16
AU8754775A (en) 1977-06-23
SU603340A3 (ru) 1978-04-15
GR59204B (en) 1977-11-26
CA1036159A (fr) 1978-08-08
IE43208L (en) 1976-06-21
GB1517710A (en) 1978-07-12
PH11810A (en) 1978-07-10
IL48697A (en) 1979-07-25
ES443738A1 (es) 1977-04-16
BG25518A3 (en) 1978-10-10
NL7514837A (nl) 1976-06-23
DK137677B (da) 1978-04-17
DD124984A5 (fr) 1977-03-23
BE836898A (fr) 1976-06-21
HU174673B (hu) 1980-03-28
AU501889B2 (en) 1979-07-05
US3998953A (en) 1976-12-21
CH628346A5 (de) 1982-02-26
DK571875A (da) 1976-06-22
PL99165B1 (pl) 1978-06-30
SE420493B (sv) 1981-10-12
DE2460929C2 (fr) 1987-12-17
CS191289B2 (en) 1979-06-29
LU73972A1 (fr) 1977-02-15
ES451457A1 (es) 1977-10-01
AT341540B (de) 1978-02-10
DE2460929A1 (de) 1976-06-24
SE7514477L (sv) 1976-06-22

Similar Documents

Publication Publication Date Title
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO145657C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkenderivater.
NO142034C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere.
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO149035C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO141717C (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive triazolopyridaziner
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
NO143459C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive 2-fenylimino-imidazolidin-derivater
NO140496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7504842L (sv) Forfarande for framstellning av adeninderivat..
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
NO144928C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater.
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO143317C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazindioksyder
SE428015B (sv) Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider
NO147483C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner.
NO142525C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive isotiourinstoff-forbindelser